However, the apparent enrichment of BRCA1/BRCA2 mutation carriers among ovarian cancer cases with a prior or coincident invasive breast cancer would advocate genetic testing of ovarian cancer cases with breast cancer in the French Canadian population. Here, BRCA2 is linked to breast carcinoma.